1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Influenza A and B Infections Global Clinical Trials Review, H2, 2014

Influenza A and B Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Influenza A and B Infections Global Clinical Trials Review, H2, 2014" provides data on the Influenza A and B Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza A and B Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza A and B Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Influenza A and B Infections Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Influenza A and B Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Influenza A and B Infections 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Influenza A and B Infections Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Daiichi Sankyo Company, Limited 32
Clinical Trial Overview of Daiichi Sankyo Company, Limited 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Microgen Scientific Industrial Company for Immunobiological Medicines 35
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 35
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd 36
Clinical Trial Overview of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd 36
Crucell N.V. 37
Clinical Trial Overview of Crucell N.V. 37
Biota Pharmaceuticals, Inc. 38
Clinical Trial Overview of Biota Pharmaceuticals, Inc. 38
Biota Holdings Limited (Inactive) 39
Clinical Trial Overview of Biota Holdings Limited (Inactive) 39
Beech Tree Labs, Inc. 40
Clinical Trial Overview of Beech Tree Labs, Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Clinical Trial Overview of Top Institutes / Government 42
British Columbia Centre for Disease Control 42
Clinical Trial Overview of British Columbia Centre for Disease Control 42
West China Hospital 43
Clinical Trial Overview of West China Hospital 43
Nagasaki Evaluation Organization for Clinical Interventions 44
Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions 44
TJ-27 Influenza study group 45
Clinical Trial Overview of TJ-27 Influenza study group 45
The National Institute of Allergy and Infectious Diseases 46
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46
Fukuoka University 47
Clinical Trial Overview of Fukuoka University 47
University of Manitoba 48
Clinical Trial Overview of University of Manitoba 48
University of Surrey 49
Clinical Trial Overview of University of Surrey 49
Five Key Clinical Profiles 50
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Influenza A and B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Influenza A and B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Influenza A and B Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Influenza A and B Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Influenza A and B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Influenza A and B Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Influenza A and B Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Influenza A and B Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Influenza A and B Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Influenza A and B Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Influenza A and B Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Influenza A and B Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Influenza A and B Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 32
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 34
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014* 35
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd, 2014* 36
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell N.V., 2014* 37
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Biota Pharmaceuticals, Inc., 2014* 38
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Biota Holdings Limited (Inactive), 2014* 39
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Beech Tree Labs, Inc., 2014* 40
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 41
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by British Columbia Centre for Disease Control, 2014* 42
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2014* 43
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014* 44
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by TJ-27 Influenza study group, 2014* 45
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 46
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fukuoka University, 2014* 47
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 48
Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Surrey, 2014* 49

List of Figures
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Influenza A and B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Influenza A and B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Influenza A and B Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Influenza A and B Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Influenza A and B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Influenza A and B Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Influenza A and B Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Influenza A and B Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Influenza A and B Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Influenza A and B Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Influenza A and B Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Influenza A and B Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.